Insider filing · DGX
J. E. Davis
CEO and President
profile →
Quest Diagnostics Incorporated
DGX · Healthcare · 49 filings in 24 months
ticker →
J. E. Davis sold $10.6M of Quest Diagnostics Incorporated (DGX)
Executed Nov 25 2025, disclosed Nov 28 2025, 3 days later.
Value, as filed
$10.6M
55,093 sh across 3 lots
Executed
Nov 25 2025
the trade date, as filed
Disclosed
Nov 28 2025
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JDJ. E. Davis (CEO and President) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Quest Diagnostics Incorporated (DGX). The largest single filing was $10.6M of DGX (55,093 sh across 3 lots, as filed), executed Nov 25 2025.
The name
DGXHealthcare · Quest Diagnostics Incorporated provides diagnostic testing and services in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by J. E. Davis in DGX
DGXSALE
Quest Diagnostics Incorporated
$2.4M10,000 sh × $242.72
Exec Sep 1
Filed Sep 3 · 5:05 PM ET DGXSALE Quest Diagnostics Incorporated $1.9M
10,000 sh × $194.14
Exec Jun 1
Filed Jun 2 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $2.1M
10,000 sh × $212.52
Exec Mar 2
Filed Mar 4 · 5:30 PM ET DGXSALE Quest Diagnostics Incorporated $6.4M
37,887 sh across 12 lots
Exec Apr 2 2025
Filed Apr 4 2025 · 5:30 PM ET